Nextage Innovation

An Israeli company involved in cannabis-based products and drug delivery platforms.

Incubator Ness Ziona, Israel Est. 2018
Visit website ↗
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

Nextage Innovation is an Israeli company with activities in cannabis-based pharmaceutical products and advanced drug delivery systems. It operates as a subsidiary of Nextar Chempharma Solutions and has been involved in developing cannabis products and technologies for the food and beverage industry. Another related entity, Nextage Therapeutics, focuses on targeted nano-liposomes based drug delivery, particularly for glioblastoma treatment, and also provides CDMO services.

Portfolio

No portfolio companies in this dataset yet.

Q&A

What is Nextage Innovation's primary focus?
Nextage Innovation operates as an "All Inclusive" innovation center specifically for cannabis-based products. It holds a license from the Israeli Ministry of Health for the development, testing, and manufacturing (GMP) of cannabis products.
When was Nextage Innovation founded?
Nextage Innovation was founded in July 2018.
Who founded Nextage Innovation?
Nextage Innovation was created by Nextar, a CDMO specializing in the development and manufacturing of pharmaceuticals and medical devices.
What kind of program does Nextage Innovation offer?
Nextage Innovation offers an R&D-focused, 6-month accelerator program designed to foster innovation in cannabis. The program provides a working lab, co-working facility, mentoring, access to Nextage's global partnerships, and an initial investment of $100,000.
What is the total AUM for Nextage Innovation?
Nextage Innovation has a total AUM of $400,000.
Who is the CEO of Nextage Innovation?
Abraham Dreazen serves as the CEO of Nextage Innovation.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)